Type 2 Diabetes Trial, Not Yet Recruiting NCT07441187 Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07441187
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 to 70 years old at the time of signing the consent form.
  • People who have been diagnosed with type 2 diabetes.
  • People who are willing to take part voluntarily and sign a consent form (if someone cannot read the form, an impartial witness must be present and also sign).
  • People who are newly diagnosed with type 2 diabetes within the past 90 days, have never taken any diabetes medication, and have a blood sugar control reading (HbA1c) between 8.0% and 11.0% at screening.
  • OR people who have been taking one oral diabetes medication for at least 60 days before screening (on a stable dose for at least the last 30 days), with a blood sugar control reading (HbA1c) between 7.0% and 11.0% at screening — eligible medications include metformin, alpha-glucosidase inhibitors, sulfonylureas, glinides, thiazolidinediones, SGLT2 inhibitors, DPP-4 inhibitors, glucokinase activators, or oral GLP-1 receptor agonists (confirm with trial site).
  • People with a Body Mass Index (BMI) greater than 19 and no more than 40.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with type 1 diabetes, a rare inherited form of diabetes, diabetes caused by pancreatic damage, or diabetes caused by another medical condition such as Cushing's syndrome or acromegaly.
  • People whose blood test shows a certain marker of insulin production (fasting C-peptide) is below a specific level, as measured by a local laboratory.
  • People with a known or suspected allergy or sensitivity to the study drug or similar compounds.
  • People who have taken part in another clinical drug trial within the past 3 months.
  • People who have used traditional Chinese herbal medicine to control their blood sugar within the past 2 months (unless total use was 7 days or fewer).
  • People who have had a serious diabetes-related emergency such as ketoacidosis, lactic acidosis, or hyperosmolar coma within the past 6 months.
  • People who have had severe heart failure, unstable chest pain, a stroke or mini-stroke, a heart attack, a serious heart rhythm problem, or heart or blood vessel surgery within the past 6 months.
  • People who have had a serious infection, major injury, or major surgery within the past 30 days.
  • People with a history of acute or chronic inflammation of the pancreas (pancreatitis).
  • People with a cancer diagnosis and a life expectancy of less than one year, active tuberculosis, or an acute infection.
  • People with a current or recurring history of urinary tract infections or genital infections.
  • People with high blood pressure that remains uncontrolled despite medication, specifically with readings above 180/110 mmHg.
  • People with a very low blood pressure reading (below 90 mmHg systolic) at the screening visit, or those the doctor considers to be low in fluid volume.
  • People with moderate to severe kidney disease, end-stage kidney disease, or those currently on dialysis.
  • People of childbearing potential who are unwilling to use effective contraception during the trial, or people who are pregnant or breastfeeding.
  • People with significantly elevated liver enzyme levels (ALT or AST more than 3 times the upper limit of normal, or total bilirubin more than 2 times the upper limit of normal) on blood tests.
  • People who the trial investigator considers unsuitable for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
20 February 2026
Est. completion
31 December 2027

Primary endpoints

Change in HbA1c from baseline to Week 24.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov